| DNA & RNA Element - Circ2Traits | | Common miRNA | Target mRNAs | Circular RNAs | Disease |
|---|
| hsa-miR-372 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000125514.5, ENSG00000126005.10, ENSG00000163364.4, ENSG00000167117.3, ENSG00000170858.5, ENSG00000170983.3, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175611.6, ENSG00000175772.10, ENSG00000175967.3, ENSG00000176728.3, ENSG00000177640.11, ENSG00000177699.4, ENSG00000177738.3, ENSG00000177993.3, ENSG00000178457.3, ENSG00000179136.1, ENSG00000179219.5, ENSG00000179523.4, ENSG00000179743.2, ENSG00000179818.6, | hsa_circ_000531, hsa_circ_000541, hsa_circ_002010, hsa_circ_001068, hsa_circ_001069, hsa_circ_000611, hsa_circ_000527, hsa_circ_001217, hsa_circ_001839, hsa_circ_002024, hsa_circ_001348, hsa_circ_001552, hsa_circ_000782, hsa_circ_001747, hsa_circ_000094, hsa_circ_000535, hsa_circ_001044, hsa_circ_000577, hsa_circ_001246, hsa_circ_000586, hsa_circ_000845, hsa_circ_000178, hsa_circ_000849, hsa_circ_000853, hsa_circ_002060, hsa_circ_001080, hsa_circ_001851, hsa_circ_002062, hsa_circ_000877, hsa_circ_000878, hsa_circ_000233, hsa_circ_000640, hsa_circ_001634, hsa_circ_000688, hsa_circ_001128, hsa_circ_001114, hsa_circ_001882, hsa_circ_001282, hsa_circ_000919, hsa_circ_001972, hsa_circ_000697, hsa_circ_001860, hsa_circ_002170, hsa_circ_001150, hsa_circ_000712, hsa_circ_000722, hsa_circ_001600, hsa_circ_000748, hsa_circ_001180, hsa_circ_002079, hsa_circ_001864, hsa_circ_001832, hsa_circ_001175, hsa_circ_001320, hsa_circ_000012, hsa_circ_000753, hsa_circ_001833, hsa_circ_000020, hsa_circ_001783, hsa_circ_000767, hsa_circ_000772, hsa_circ_002056, hsa_circ_001835 | acute myeloid leukemia (AML), down-regulated, microarray, 2008, Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | acute myeloid leukemia (AML), up-regulated, microarray, 2008, Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | acute myeloid leukemia (AML), up-regulated, microarray, 2008, Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. | | hsa-miR-128 | ENSG00000083622.8, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124915.6, ENSG00000129816.5, ENSG00000129845.5, ENSG00000131538.6, ENSG00000131548.6, ENSG00000136315.3, ENSG00000146666.4, ENSG00000149656.4, ENSG00000152931.6, ENSG00000153363.8, ENSG00000159712.9, ENSG00000161103.6, ENSG00000167117.3, ENSG00000167355.3, ENSG00000167912.5, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175147.7, ENSG00000175611.6, ENSG00000175967.3, ENSG00000176057.5, ENSG00000176936.2, ENS | hsa_circ_000070 | anxiety disorder, normal, northern blot, qRT-PCR etc, 2009, Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. | | hsa-miR-181d | ENSG00000089336.6, ENSG00000100181.15, ENSG00000131538.6, ENSG00000131548.6, ENSG00000147753.5, ENSG00000147761.4, ENSG00000149656.4, ENSG00000152487.5, ENSG00000159712.9, ENSG00000164621.5, ENSG00000170846.11, ENSG00000173811.6, ENSG00000176057.5, ENSG00000177338.7, ENSG00000177553.6, ENSG00000177640.11, ENSG00000177699.4, ENSG00000178193.4, ENSG00000179523.4, ENSG00000180712.3, ENSG00000180769.4, ENSG00000181097.5, ENSG00000181171.5, ENSG00000182057.4, ENSG00000182376.2, ENSG00000182873.4, ENS | hsa_circ_000612, hsa_circ_000613, hsa_circ_000052, hsa_circ_000019, hsa_circ_001555, hsa_circ_002139, hsa_circ_001620, hsa_circ_001934, hsa_circ_001361, hsa_circ_001785, hsa_circ_001214, hsa_circ_000782, hsa_circ_001010, hsa_circ_000784, hsa_circ_001838, hsa_circ_000786, hsa_circ_000125, hsa_circ_002025, hsa_circ_001032, hsa_circ_001720, hsa_circ_000007, hsa_circ_002027, hsa_circ_002179, hsa_circ_000555, hsa_circ_001053, hsa_circ_000835, hsa_circ_001054, hsa_circ_000171, hsa_circ_000591, hsa_circ_001252, hsa_circ_001066, hsa_circ_000606, hsa_circ_001849, hsa_circ_001682, hsa_circ_000609, hsa_circ_001262, hsa_circ_000866, hsa_circ_001757, hsa_circ_000876, hsa_circ_002147, hsa_circ_000637, hsa_circ_001398, hsa_circ_001101, hsa_circ_001102, hsa_circ_001634, hsa_circ_002146, hsa_circ_000026*, hsa_circ_001825, hsa_circ_000910, hsa_circ_001114, hsa_circ_000916, hsa_circ_001737, hsa_circ_000919, hsa_circ_001641, hsa_circ_002132, hsa_circ_002175, hsa_circ_001142, hsa_circ_001297, hsa_circ_001944, hsa_circ_001859, hsa_circ_000029, hsa_circ_000935, hsa_circ_001829, hsa_circ_001644, hsa_circ_001704, hsa_circ_000385, hsa_circ_001862, hsa_circ_001305, hsa_circ_001770, hsa_circ_001988, hsa_circ_002067, hsa_circ_001168, hsa_circ_001180, hsa_circ_001601, hsa_circ_001175, hsa_circ_001947, hsa_circ_001543, hsa_circ_001193, hsa_circ_001612, hsa_circ_001783, hsa_circ_002005, hsa_circ_001204, hsa_circ_000761, hsa_circ_001004, hsa_circ_001615, hsa_circ_002116, hsa_circ_001210, hsa_circ_001211 | autism spectrum disorder (ASD), down-regulated, microarray, 2008, Heterogeneous dysregulation of microRNAs across the autism spectrum. | | hsa-miR-153 | ENSG00000100181.15, ENSG00000125514.5, ENSG00000161103.6, ENSG00000162947.4, ENSG00000166917.6, ENSG00000167117.3, ENSG00000175967.3, ENSG00000177553.6, ENSG00000177640.11, ENSG00000179141.3, ENSG00000179935.5, ENSG00000180139.7, ENSG00000180769.4, ENSG00000182376.2, ENSG00000186842.4, ENSG00000187156.4, ENSG00000187229.3, ENSG00000188660.3, ENSG00000188693.7, ENSG00000188933.5, ENSG00000189149.7, ENSG00000189229.10, ENSG00000196421.3, ENSG00000196951.5, ENSG00000197176.3, ENSG00000197210.6, ENS | hsa_circ_001229 | B-cell chronic lymphocytic leukemia, up-regulated, microarray, 2004, MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. | | hsa-miR-181d | ENSG00000089336.6, ENSG00000100181.15, ENSG00000131538.6, ENSG00000131548.6, ENSG00000147753.5, ENSG00000147761.4, ENSG00000149656.4, ENSG00000152487.5, ENSG00000159712.9, ENSG00000164621.5, ENSG00000170846.11, ENSG00000173811.6, ENSG00000176057.5, ENSG00000177338.7, ENSG00000177553.6, ENSG00000177640.11, ENSG00000177699.4, ENSG00000178193.4, ENSG00000179523.4, ENSG00000180712.3, ENSG00000180769.4, ENSG00000181097.5, ENSG00000181171.5, ENSG00000182057.4, ENSG00000182376.2, ENSG00000182873.4, ENS | hsa_circ_000612, hsa_circ_000613, hsa_circ_000052, hsa_circ_000019, hsa_circ_001555, hsa_circ_002139, hsa_circ_001620, hsa_circ_001934, hsa_circ_001361, hsa_circ_001785, hsa_circ_001214, hsa_circ_000782, hsa_circ_001010, hsa_circ_000784, hsa_circ_001838, hsa_circ_000786, hsa_circ_000125, hsa_circ_002025, hsa_circ_001032, hsa_circ_001720, hsa_circ_000007, hsa_circ_002027, hsa_circ_002179, hsa_circ_000555, hsa_circ_001053, hsa_circ_000835, hsa_circ_001054, hsa_circ_000171, hsa_circ_000591, hsa_circ_001252, hsa_circ_001066, hsa_circ_000606, hsa_circ_001849, hsa_circ_001682, hsa_circ_000609, hsa_circ_001262, hsa_circ_000866, hsa_circ_001757, hsa_circ_000876, hsa_circ_002147, hsa_circ_000637, hsa_circ_001398, hsa_circ_001101, hsa_circ_001102, hsa_circ_001634, hsa_circ_002146, hsa_circ_000026*, hsa_circ_001825, hsa_circ_000910, hsa_circ_001114, hsa_circ_000916, hsa_circ_001737, hsa_circ_000919, hsa_circ_001641, hsa_circ_002132, hsa_circ_002175, hsa_circ_001142, hsa_circ_001297, hsa_circ_001944, hsa_circ_001859, hsa_circ_000029, hsa_circ_000935, hsa_circ_001829, hsa_circ_001644, hsa_circ_001704, hsa_circ_000385, hsa_circ_001862, hsa_circ_001305, hsa_circ_001770, hsa_circ_001988, hsa_circ_002067, hsa_circ_001168, hsa_circ_001180, hsa_circ_001601, hsa_circ_001175, hsa_circ_001947, hsa_circ_001543, hsa_circ_001193, hsa_circ_001612, hsa_circ_001783, hsa_circ_002005, hsa_circ_001204, hsa_circ_000761, hsa_circ_001004, hsa_circ_001615, hsa_circ_002116, hsa_circ_001210, hsa_circ_001211 | breast cancer, up-regulated, microarray, 2008, MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. | | hsa-miR-372 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000125514.5, ENSG00000126005.10, ENSG00000163364.4, ENSG00000167117.3, ENSG00000170858.5, ENSG00000170983.3, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175611.6, ENSG00000175772.10, ENSG00000175967.3, ENSG00000176728.3, ENSG00000177640.11, ENSG00000177699.4, ENSG00000177738.3, ENSG00000177993.3, ENSG00000178457.3, ENSG00000179136.1, ENSG00000179219.5, ENSG00000179523.4, ENSG00000179743.2, ENSG00000179818.6, | hsa_circ_000531, hsa_circ_000541, hsa_circ_002010, hsa_circ_001068, hsa_circ_001069, hsa_circ_000611, hsa_circ_000527, hsa_circ_001217, hsa_circ_001839, hsa_circ_002024, hsa_circ_001348, hsa_circ_001552, hsa_circ_000782, hsa_circ_001747, hsa_circ_000094, hsa_circ_000535, hsa_circ_001044, hsa_circ_000577, hsa_circ_001246, hsa_circ_000586, hsa_circ_000845, hsa_circ_000178, hsa_circ_000849, hsa_circ_000853, hsa_circ_002060, hsa_circ_001080, hsa_circ_001851, hsa_circ_002062, hsa_circ_000877, hsa_circ_000878, hsa_circ_000233, hsa_circ_000640, hsa_circ_001634, hsa_circ_000688, hsa_circ_001128, hsa_circ_001114, hsa_circ_001882, hsa_circ_001282, hsa_circ_000919, hsa_circ_001972, hsa_circ_000697, hsa_circ_001860, hsa_circ_002170, hsa_circ_001150, hsa_circ_000712, hsa_circ_000722, hsa_circ_001600, hsa_circ_000748, hsa_circ_001180, hsa_circ_002079, hsa_circ_001864, hsa_circ_001832, hsa_circ_001175, hsa_circ_001320, hsa_circ_000012, hsa_circ_000753, hsa_circ_001833, hsa_circ_000020, hsa_circ_001783, hsa_circ_000767, hsa_circ_000772, hsa_circ_002056, hsa_circ_001835 | colorectal cancer, up-regulated, Northern blot, qRT-PCR etc, 2006, Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. | | hsa-miR-181d | ENSG00000089336.6, ENSG00000100181.15, ENSG00000131538.6, ENSG00000131548.6, ENSG00000147753.5, ENSG00000147761.4, ENSG00000149656.4, ENSG00000152487.5, ENSG00000159712.9, ENSG00000164621.5, ENSG00000170846.11, ENSG00000173811.6, ENSG00000176057.5, ENSG00000177338.7, ENSG00000177553.6, ENSG00000177640.11, ENSG00000177699.4, ENSG00000178193.4, ENSG00000179523.4, ENSG00000180712.3, ENSG00000180769.4, ENSG00000181097.5, ENSG00000181171.5, ENSG00000182057.4, ENSG00000182376.2, ENSG00000182873.4, ENS | hsa_circ_000612, hsa_circ_000613, hsa_circ_000052, hsa_circ_000019, hsa_circ_001555, hsa_circ_002139, hsa_circ_001620, hsa_circ_001934, hsa_circ_001361, hsa_circ_001785, hsa_circ_001214, hsa_circ_000782, hsa_circ_001010, hsa_circ_000784, hsa_circ_001838, hsa_circ_000786, hsa_circ_000125, hsa_circ_002025, hsa_circ_001032, hsa_circ_001720, hsa_circ_000007, hsa_circ_002027, hsa_circ_002179, hsa_circ_000555, hsa_circ_001053, hsa_circ_000835, hsa_circ_001054, hsa_circ_000171, hsa_circ_000591, hsa_circ_001252, hsa_circ_001066, hsa_circ_000606, hsa_circ_001849, hsa_circ_001682, hsa_circ_000609, hsa_circ_001262, hsa_circ_000866, hsa_circ_001757, hsa_circ_000876, hsa_circ_002147, hsa_circ_000637, hsa_circ_001398, hsa_circ_001101, hsa_circ_001102, hsa_circ_001634, hsa_circ_002146, hsa_circ_000026*, hsa_circ_001825, hsa_circ_000910, hsa_circ_001114, hsa_circ_000916, hsa_circ_001737, hsa_circ_000919, hsa_circ_001641, hsa_circ_002132, hsa_circ_002175, hsa_circ_001142, hsa_circ_001297, hsa_circ_001944, hsa_circ_001859, hsa_circ_000029, hsa_circ_000935, hsa_circ_001829, hsa_circ_001644, hsa_circ_001704, hsa_circ_000385, hsa_circ_001862, hsa_circ_001305, hsa_circ_001770, hsa_circ_001988, hsa_circ_002067, hsa_circ_001168, hsa_circ_001180, hsa_circ_001601, hsa_circ_001175, hsa_circ_001947, hsa_circ_001543, hsa_circ_001193, hsa_circ_001612, hsa_circ_001783, hsa_circ_002005, hsa_circ_001204, hsa_circ_000761, hsa_circ_001004, hsa_circ_001615, hsa_circ_002116, hsa_circ_001210, hsa_circ_001211 | Duchenne muscular dystrophy (DMD), up-regulated, microarray, 2007, Distinctive patterns of microRNA expression in primary muscular disorders. | | hsa-miR-153 | ENSG00000100181.15, ENSG00000125514.5, ENSG00000161103.6, ENSG00000162947.4, ENSG00000166917.6, ENSG00000167117.3, ENSG00000175967.3, ENSG00000177553.6, ENSG00000177640.11, ENSG00000179141.3, ENSG00000179935.5, ENSG00000180139.7, ENSG00000180769.4, ENSG00000182376.2, ENSG00000186842.4, ENSG00000187156.4, ENSG00000187229.3, ENSG00000188660.3, ENSG00000188693.7, ENSG00000188933.5, ENSG00000189149.7, ENSG00000189229.10, ENSG00000196421.3, ENSG00000196951.5, ENSG00000197176.3, ENSG00000197210.6, ENS | hsa_circ_001229 | glioblastoma multiforme (GBM), down-regulated, Northern blot, qRT-PCR etc, 2008, miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. | | hsa-miR-153 | ENSG00000100181.15, ENSG00000125514.5, ENSG00000161103.6, ENSG00000162947.4, ENSG00000166917.6, ENSG00000167117.3, ENSG00000175967.3, ENSG00000177553.6, ENSG00000177640.11, ENSG00000179141.3, ENSG00000179935.5, ENSG00000180139.7, ENSG00000180769.4, ENSG00000182376.2, ENSG00000186842.4, ENSG00000187156.4, ENSG00000187229.3, ENSG00000188660.3, ENSG00000188693.7, ENSG00000188933.5, ENSG00000189149.7, ENSG00000189229.10, ENSG00000196421.3, ENSG00000196951.5, ENSG00000197176.3, ENSG00000197210.6, ENS | hsa_circ_001229 | glioblastoma, down-regulated, northern blot, qRT-PCR etc, 2009, Down-regulations of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) by MicroRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. | | hsa-miR-128 | ENSG00000083622.8, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124915.6, ENSG00000129816.5, ENSG00000129845.5, ENSG00000131538.6, ENSG00000131548.6, ENSG00000136315.3, ENSG00000146666.4, ENSG00000149656.4, ENSG00000152931.6, ENSG00000153363.8, ENSG00000159712.9, ENSG00000161103.6, ENSG00000167117.3, ENSG00000167355.3, ENSG00000167912.5, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175147.7, ENSG00000175611.6, ENSG00000175967.3, ENSG00000176057.5, ENSG00000176936.2, ENS | hsa_circ_000070 | glioma, down-regulated, Northern blot, qRT-PCR etc, 2008, MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | multiple sclerosis, up-regulated, northern blot, qRT-PCR etc, 2009, MicroRNA miR-326 regulates T(H)-17 differentiation and is associated with the pathogenesis of multiple sclerosis | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | multiple sclerosis, up-regulated, northern blot, qRT-PCR etc, 2009, MicroRNA miR-326 regulates T(H)-17 differentiation and is associated with the pathogenesis of multiple sclerosis | | hsa-miR-181d | ENSG00000089336.6, ENSG00000100181.15, ENSG00000131538.6, ENSG00000131548.6, ENSG00000147753.5, ENSG00000147761.4, ENSG00000149656.4, ENSG00000152487.5, ENSG00000159712.9, ENSG00000164621.5, ENSG00000170846.11, ENSG00000173811.6, ENSG00000176057.5, ENSG00000177338.7, ENSG00000177553.6, ENSG00000177640.11, ENSG00000177699.4, ENSG00000178193.4, ENSG00000179523.4, ENSG00000180712.3, ENSG00000180769.4, ENSG00000181097.5, ENSG00000181171.5, ENSG00000182057.4, ENSG00000182376.2, ENSG00000182873.4, ENS | hsa_circ_000612, hsa_circ_000613, hsa_circ_000052, hsa_circ_000019, hsa_circ_001555, hsa_circ_002139, hsa_circ_001620, hsa_circ_001934, hsa_circ_001361, hsa_circ_001785, hsa_circ_001214, hsa_circ_000782, hsa_circ_001010, hsa_circ_000784, hsa_circ_001838, hsa_circ_000786, hsa_circ_000125, hsa_circ_002025, hsa_circ_001032, hsa_circ_001720, hsa_circ_000007, hsa_circ_002027, hsa_circ_002179, hsa_circ_000555, hsa_circ_001053, hsa_circ_000835, hsa_circ_001054, hsa_circ_000171, hsa_circ_000591, hsa_circ_001252, hsa_circ_001066, hsa_circ_000606, hsa_circ_001849, hsa_circ_001682, hsa_circ_000609, hsa_circ_001262, hsa_circ_000866, hsa_circ_001757, hsa_circ_000876, hsa_circ_002147, hsa_circ_000637, hsa_circ_001398, hsa_circ_001101, hsa_circ_001102, hsa_circ_001634, hsa_circ_002146, hsa_circ_000026*, hsa_circ_001825, hsa_circ_000910, hsa_circ_001114, hsa_circ_000916, hsa_circ_001737, hsa_circ_000919, hsa_circ_001641, hsa_circ_002132, hsa_circ_002175, hsa_circ_001142, hsa_circ_001297, hsa_circ_001944, hsa_circ_001859, hsa_circ_000029, hsa_circ_000935, hsa_circ_001829, hsa_circ_001644, hsa_circ_001704, hsa_circ_000385, hsa_circ_001862, hsa_circ_001305, hsa_circ_001770, hsa_circ_001988, hsa_circ_002067, hsa_circ_001168, hsa_circ_001180, hsa_circ_001601, hsa_circ_001175, hsa_circ_001947, hsa_circ_001543, hsa_circ_001193, hsa_circ_001612, hsa_circ_001783, hsa_circ_002005, hsa_circ_001204, hsa_circ_000761, hsa_circ_001004, hsa_circ_001615, hsa_circ_002116, hsa_circ_001210, hsa_circ_001211 | nemaline myopathy (NM), up-regulated, microarray, 2007, Distinctive patterns of microRNA expression in primary muscular disorders. | | hsa-miR-372 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000125514.5, ENSG00000126005.10, ENSG00000163364.4, ENSG00000167117.3, ENSG00000170858.5, ENSG00000170983.3, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175611.6, ENSG00000175772.10, ENSG00000175967.3, ENSG00000176728.3, ENSG00000177640.11, ENSG00000177699.4, ENSG00000177738.3, ENSG00000177993.3, ENSG00000178457.3, ENSG00000179136.1, ENSG00000179219.5, ENSG00000179523.4, ENSG00000179743.2, ENSG00000179818.6, | hsa_circ_000531, hsa_circ_000541, hsa_circ_002010, hsa_circ_001068, hsa_circ_001069, hsa_circ_000611, hsa_circ_000527, hsa_circ_001217, hsa_circ_001839, hsa_circ_002024, hsa_circ_001348, hsa_circ_001552, hsa_circ_000782, hsa_circ_001747, hsa_circ_000094, hsa_circ_000535, hsa_circ_001044, hsa_circ_000577, hsa_circ_001246, hsa_circ_000586, hsa_circ_000845, hsa_circ_000178, hsa_circ_000849, hsa_circ_000853, hsa_circ_002060, hsa_circ_001080, hsa_circ_001851, hsa_circ_002062, hsa_circ_000877, hsa_circ_000878, hsa_circ_000233, hsa_circ_000640, hsa_circ_001634, hsa_circ_000688, hsa_circ_001128, hsa_circ_001114, hsa_circ_001882, hsa_circ_001282, hsa_circ_000919, hsa_circ_001972, hsa_circ_000697, hsa_circ_001860, hsa_circ_002170, hsa_circ_001150, hsa_circ_000712, hsa_circ_000722, hsa_circ_001600, hsa_circ_000748, hsa_circ_001180, hsa_circ_002079, hsa_circ_001864, hsa_circ_001832, hsa_circ_001175, hsa_circ_001320, hsa_circ_000012, hsa_circ_000753, hsa_circ_001833, hsa_circ_000020, hsa_circ_001783, hsa_circ_000767, hsa_circ_000772, hsa_circ_002056, hsa_circ_001835 | non-small cell lung cancer (NSCLC), up-regulated, Northern blot, qRT-PCR etc, 2008, MicroRNA signature predicts survival and relapse in lung cancer. | | hsa-miR-181d | ENSG00000089336.6, ENSG00000100181.15, ENSG00000131538.6, ENSG00000131548.6, ENSG00000147753.5, ENSG00000147761.4, ENSG00000149656.4, ENSG00000152487.5, ENSG00000159712.9, ENSG00000164621.5, ENSG00000170846.11, ENSG00000173811.6, ENSG00000176057.5, ENSG00000177338.7, ENSG00000177553.6, ENSG00000177640.11, ENSG00000177699.4, ENSG00000178193.4, ENSG00000179523.4, ENSG00000180712.3, ENSG00000180769.4, ENSG00000181097.5, ENSG00000181171.5, ENSG00000182057.4, ENSG00000182376.2, ENSG00000182873.4, ENS | hsa_circ_000612, hsa_circ_000613, hsa_circ_000052, hsa_circ_000019, hsa_circ_001555, hsa_circ_002139, hsa_circ_001620, hsa_circ_001934, hsa_circ_001361, hsa_circ_001785, hsa_circ_001214, hsa_circ_000782, hsa_circ_001010, hsa_circ_000784, hsa_circ_001838, hsa_circ_000786, hsa_circ_000125, hsa_circ_002025, hsa_circ_001032, hsa_circ_001720, hsa_circ_000007, hsa_circ_002027, hsa_circ_002179, hsa_circ_000555, hsa_circ_001053, hsa_circ_000835, hsa_circ_001054, hsa_circ_000171, hsa_circ_000591, hsa_circ_001252, hsa_circ_001066, hsa_circ_000606, hsa_circ_001849, hsa_circ_001682, hsa_circ_000609, hsa_circ_001262, hsa_circ_000866, hsa_circ_001757, hsa_circ_000876, hsa_circ_002147, hsa_circ_000637, hsa_circ_001398, hsa_circ_001101, hsa_circ_001102, hsa_circ_001634, hsa_circ_002146, hsa_circ_000026*, hsa_circ_001825, hsa_circ_000910, hsa_circ_001114, hsa_circ_000916, hsa_circ_001737, hsa_circ_000919, hsa_circ_001641, hsa_circ_002132, hsa_circ_002175, hsa_circ_001142, hsa_circ_001297, hsa_circ_001944, hsa_circ_001859, hsa_circ_000029, hsa_circ_000935, hsa_circ_001829, hsa_circ_001644, hsa_circ_001704, hsa_circ_000385, hsa_circ_001862, hsa_circ_001305, hsa_circ_001770, hsa_circ_001988, hsa_circ_002067, hsa_circ_001168, hsa_circ_001180, hsa_circ_001601, hsa_circ_001175, hsa_circ_001947, hsa_circ_001543, hsa_circ_001193, hsa_circ_001612, hsa_circ_001783, hsa_circ_002005, hsa_circ_001204, hsa_circ_000761, hsa_circ_001004, hsa_circ_001615, hsa_circ_002116, hsa_circ_001210, hsa_circ_001211 | pancreatic cancer, up-regulated, Northern blot, qRT-PCR etc, 2007, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | primary biliary cirrhosis (PBC), down-regulated, microarray, 2008, WITHDRAWN:MicroRNA profile in peripheral blood T cells of patients with primary biliary cirrhosis. | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | primary biliary cirrhosis (PBC), down-regulated, microarray, 2008, WITHDRAWN:MicroRNA profile in peripheral blood T cells of patients with primary biliary cirrhosis. | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | psoriasis, down-regulated, microarray, 2007, MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? | | hsa-miR-326 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000126005.10, ENSG00000126005.10, ENSG00000131007.5, ENSG00000131009.4, ENSG00000132832.4, ENSG00000132832.4, ENSG00000141028.4, ENSG00000141028.4, ENSG00000145063.9, ENSG00000152931.6, ENSG00000159712.9, ENSG00000161103.6, ENSG00000164621.5, ENSG00000164621.5, ENSG00000167117.3, ENSG00000170846.11, ENSG00000170858.5, ENSG00000170983.3, ENSG00000173811.6, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175061.9, | hsa_circ_000614 | psoriasis, down-regulated, microarray, 2007, MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? | | hsa-miR-372 | ENSG00000089336.6, ENSG00000100181.15, ENSG00000117242.7, ENSG00000124835.2, ENSG00000125514.5, ENSG00000126005.10, ENSG00000163364.4, ENSG00000167117.3, ENSG00000170858.5, ENSG00000170983.3, ENSG00000174365.14, ENSG00000174403.11, ENSG00000175611.6, ENSG00000175772.10, ENSG00000175967.3, ENSG00000176728.3, ENSG00000177640.11, ENSG00000177699.4, ENSG00000177738.3, ENSG00000177993.3, ENSG00000178457.3, ENSG00000179136.1, ENSG00000179219.5, ENSG00000179523.4, ENSG00000179743.2, ENSG00000179818.6, | hsa_circ_000531, hsa_circ_000541, hsa_circ_002010, hsa_circ_001068, hsa_circ_001069, hsa_circ_000611, hsa_circ_000527, hsa_circ_001217, hsa_circ_001839, hsa_circ_002024, hsa_circ_001348, hsa_circ_001552, hsa_circ_000782, hsa_circ_001747, hsa_circ_000094, hsa_circ_000535, hsa_circ_001044, hsa_circ_000577, hsa_circ_001246, hsa_circ_000586, hsa_circ_000845, hsa_circ_000178, hsa_circ_000849, hsa_circ_000853, hsa_circ_002060, hsa_circ_001080, hsa_circ_001851, hsa_circ_002062, hsa_circ_000877, hsa_circ_000878, hsa_circ_000233, hsa_circ_000640, hsa_circ_001634, hsa_circ_000688, hsa_circ_001128, hsa_circ_001114, hsa_circ_001882, hsa_circ_001282, hsa_circ_000919, hsa_circ_001972, hsa_circ_000697, hsa_circ_001860, hsa_circ_002170, hsa_circ_001150, hsa_circ_000712, hsa_circ_000722, hsa_circ_001600, hsa_circ_000748, hsa_circ_001180, hsa_circ_002079, hsa_circ_001864, hsa_circ_001832, hsa_circ_001175, hsa_circ_001320, hsa_circ_000012, hsa_circ_000753, hsa_circ_001833, hsa_circ_000020, hsa_circ_001783, hsa_circ_000767, hsa_circ_000772, hsa_circ_002056, hsa_circ_001835 | testicular germ cell tumor, up-regulated, Northern blot, qRT-PCR etc, 2006, A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. | |